Literature DB >> 23754282

Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Masahiro Iguchi1, Yuki Kujuro, Kei Okatsu, Fumika Koyano, Hidetaka Kosako, Mayumi Kimura, Norihiro Suzuki, Shinichiro Uchiyama, Keiji Tanaka, Noriyuki Matsuda.   

Abstract

PINK1 and PARKIN are causal genes for autosomal recessive familial Parkinsonism. PINK1 is a mitochondrial Ser/Thr kinase, whereas Parkin functions as an E3 ubiquitin ligase. Under steady-state conditions, Parkin localizes to the cytoplasm where its E3 activity is repressed. A decrease in mitochondrial membrane potential triggers Parkin E3 activity and recruits it to depolarized mitochondria for ubiquitylation of mitochondrial substrates. The molecular basis for how the E3 activity of Parkin is re-established by mitochondrial damage has yet to be determined. Here we provide in vitro biochemical evidence for ubiquitin-thioester formation on Cys-431 of recombinant Parkin. We also report that Parkin forms a ubiquitin-ester following a decrease in mitochondrial membrane potential in cells, and that this event is essential for substrate ubiquitylation. Importantly, the Parkin RING2 domain acts as a transthiolation or acyl-transferring domain rather than an E2-recruiting domain. Furthermore, formation of the ubiquitin-ester depends on PINK1 phosphorylation of Parkin Ser-65. A phosphorylation-deficient mutation completely inhibited formation of the Parkin ubiquitin-ester intermediate, whereas phosphorylation mimics, such as Ser to Glu substitution, enabled partial formation of the intermediate irrespective of Ser-65 phosphorylation. We propose that PINK1-dependent phosphorylation of Parkin leads to the ubiquitin-ester transfer reaction of the RING2 domain, and that this is an essential step in Parkin activation.

Entities:  

Keywords:  Mitochondria; Parkin; Pink1; RING Finger; Ubiquitin; Ubiquitin Ligase

Mesh:

Substances:

Year:  2013        PMID: 23754282      PMCID: PMC3724655          DOI: 10.1074/jbc.M113.467530

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro.

Authors:  Noriyuki Matsuda; Toshiaki Kitami; Toshiaki Suzuki; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

2.  Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane.

Authors:  Saori R Yoshii; Chieko Kishi; Naotada Ishihara; Noboru Mizushima
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

3.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 4.  Mitophagy: the latest problem for Parkinson's disease.

Authors:  Cristofol Vives-Bauza; Serge Przedborski
Journal:  Trends Mol Med       Date:  2010-12-09       Impact factor: 11.951

5.  Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.

Authors:  Eyal Avraham; Ruth Rott; Esti Liani; Raymonde Szargel; Simone Engelender
Journal:  J Biol Chem       Date:  2007-02-27       Impact factor: 5.157

6.  Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age.

Authors:  Aaron C Pawlyk; Benoit I Giasson; Deepak M Sampathu; Francisco A Perez; Kah Leong Lim; Valina L Dawson; Ted M Dawson; Richard D Palmiter; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2003-09-12       Impact factor: 5.157

7.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.

Authors:  Yongsung Kim; Jeehye Park; Sunhong Kim; Saera Song; Seok-Kyu Kwon; Sang-Hee Lee; Tohru Kitada; Jin-Man Kim; Jongkyeong Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-10-26       Impact factor: 3.575

8.  Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy.

Authors:  Nickie C Chan; Anna M Salazar; Anh H Pham; Michael J Sweredoski; Natalie J Kolawa; Robert L J Graham; Sonja Hess; David C Chan
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

9.  Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Authors:  Matthew E Gegg; J Mark Cooper; Kai-Yin Chau; Manuel Rojo; Anthony H V Schapira; Jan-Willem Taanman
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

10.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.

Authors:  Yoichi Imaizumi; Yohei Okada; Wado Akamatsu; Masato Koike; Naoko Kuzumaki; Hideki Hayakawa; Tomoko Nihira; Tetsuro Kobayashi; Manabu Ohyama; Shigeto Sato; Masashi Takanashi; Manabu Funayama; Akiyoshi Hirayama; Tomoyoshi Soga; Takako Hishiki; Makoto Suematsu; Takuya Yagi; Daisuke Ito; Arifumi Kosakai; Kozo Hayashi; Masanobu Shouji; Atsushi Nakanishi; Norihiro Suzuki; Yoshikuni Mizuno; Noboru Mizushima; Masayuki Amagai; Yasuo Uchiyama; Hideki Mochizuki; Nobutaka Hattori; Hideyuki Okano
Journal:  Mol Brain       Date:  2012-10-06       Impact factor: 4.041

View more
  94 in total

1.  Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.

Authors:  Koji Yamano; Bruno B Queliconi; Fumika Koyano; Yasushi Saeki; Takatsugu Hirokawa; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

Review 2.  Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.

Authors:  Simone Buraschi; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2017-11-07       Impact factor: 11.583

3.  Calcium/calmodulin-dependent protein kinase regulates the PINK1/Parkin and DJ-1 pathways of mitophagy during sepsis.

Authors:  Xianghong Zhang; Du Yuan; Qian Sun; Li Xu; Emma Lee; Anthony J Lewis; Brian S Zuckerbraun; Matthew R Rosengart
Journal:  FASEB J       Date:  2017-06-14       Impact factor: 5.191

4.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

Review 5.  How mitochondrial dynamism orchestrates mitophagy.

Authors:  Orian S Shirihai; Moshi Song; Gerald W Dorn
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

Review 6.  Activation of the E3 ubiquitin ligase Parkin.

Authors:  Thomas R Caulfield; Fabienne C Fiesel; Wolfdieter Springer
Journal:  Biochem Soc Trans       Date:  2015-04       Impact factor: 5.407

Review 7.  Mitochondrial network remodeling: an important feature of myogenesis and skeletal muscle regeneration.

Authors:  Fasih Ahmad Rahman; Joe Quadrilatero
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

8.  Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.

Authors:  Seung Baek Lee; Jung Jin Kim; Hyun-Ja Nam; Bowen Gao; Ping Yin; Bo Qin; Sang-Yeop Yi; Hyoungjun Ham; Debra Evans; Sun-Hyun Kim; Jun Zhang; Min Deng; Tongzheng Liu; Haoxing Zhang; Daniel D Billadeau; Liewei Wang; Emilie Giaime; Jie Shen; Yuan-Ping Pang; Jin Jen; Jan M van Deursen; Zhenkun Lou
Journal:  Mol Cell       Date:  2015-09-17       Impact factor: 17.970

Review 9.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

Review 10.  Targeting Pink1-Parkin-mediated mitophagy for treating liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2015-10-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.